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CHAPTER 1. INTRODUCTION 
 
1.1 Introduction to HNO 
 
1.1.1 The unique qualities of HNO 
     HNO (nitrosyl hydride, nitroxyl, azanone, Figure 1.1) is a small inorganic 
molecule with unique chemical characteristics and has attracted considerable interest for 
its functions in biological systems. HNO has also been rapidly emerging as a novel entity 
with distinct pharmacology and therapeutic advantages and, it has been discovered that 
HNO has different chemical and biochemical activities than its more widely studied 
redox sibling, nitric oxide (NO).1  
 
Figure 1.1: Lewis structure of HNO 
HNO is the reduced form of NO and is thought to be formed by the enzyme-catalyzed 
reduction of NO from enzyme catalysts such as NOS catalysts. 1 It has been postulated 
that HNO can be produced directly from NOS-dependent sources in the absence of 
tetrahydrobiopterin (BH4, THB) cofactor, which is a naturally occurring cofactor for the 
enzymatic degradation of the aromatic amino acids; there is speculation that BH4 is 
required for the enzyme to serve as an NO rather than an HNO synthase.1 HNO is also 
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thought to be produced after oxidation of the NOS intermediates N-hydroxy-L-arginine 
and hydroxylamine (Figure 1.2).1, 2  
 
Figure 1.2: Possible biosynthetic pathway to HNO from the nitric oxide synthase 
(NOS) intermediate N-hydroxy-L-arginine (reproduced from Irvine)1 
This has shown potential as a physiologically relevant process since N-hydroxy-L-
arginine has been detected at significant levels (~20 µm) and is released by some cells in 
vivo.2,3 However, there is a lack of strong evidence for endogenous HNO generation, 
which can be accredited to the fact that there is currently no efficient, specific, and/or 
sensitive HNO detection method available for use in biological systems.2,3 However, in 
vitro experiments have exhibited evidence that HNO could be generated endogenously.3 
The pKa value for deprotonation of HNO to give NO
- (+ H+) is ~ 11.4, making 
HNO the biologically relevant species.3, 4, 5 The acid–base equilibrium of HNO is not 
typical because the conjugate acid and conjugate base have different electronic spin 
states.6 With typical acid–base reactions, it is normally assumed that proton transfer is 
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extremely fast such that, the equilibrium constant (Ka) is an effective indication of the 
ratio of acid and conjugate base present. However, the ground state of HNO is a singlet 
while NO− is a ground state triplet.3, 6 Since the ground states for HNO and NO− are 
different, proton transfer requires a spin state change, which is forbidden by quantum 
mechanics. Spin-forbidden processes have a low probability of occurring and thus are 
kinetically slow compared to spin-allowed processes.3, 6, 7 The consequence of the high 
kinetic barrier is that proton transfer becomes slow enough to impede the rapid 
establishment of an acid–base equilibrium between HNO and NO−.2, 6 Also, since, both 
HNO and NO− are also highly reactive species, pathways other than proton transfer could 
be more kinetically favorable. 
Another unique characteristic of HNO is that it is resistant to scavenging by 
superoxide (•O2-).1, 5 In contrast, NO reacts with superoxide to form toxic 
peroxynitrite/peroxynitrous acid (ONOO(H)).1 This property of HNO makes it more 
resistant to reaction with possible radical byproducts formed during biological processes. 
HNO, like NO, elicits vasorelaxation through cell signaling transduction.2, 5 However, 
NO eventually reaches a tolerance level in therapeutic applications, while HNO does not 
show any development of vascular tolerance and can have positive effects at low 
concentrations.1, 5 This makes it a more attractive agent for pharmacological and 
medicinal studies. HNO was discovered in the Nagasawa laboratory to have the potential 
to serve as a treatment for alcoholism.3, 6 In their studies, they found that cyanamide, an 
HNO-donating drug for treating alcoholism, is oxidatively bioactivated to produce HNO 
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which then inhibits the enzyme aldehyde dehydrogenase by interacting with the cysteine 
thiolate active site.3, 6, 8  There has been some evidence showing that the interaction of 
HNO and cyanamide also produces hydrogen cyanide (HCN) as a byproduct.3, 6 
However, there is literature stating that pharmacological use of cyanamide does not 
appear to be associated with cyanide toxicity, providing some evidence that HNO is an 
extremely potent inhibitor of aldehyde dehydrogenase, which then produces HCN at a 
threshold well below that of cyanide poisoning.3, 6 In clinical trials performed on adult 
male dogs at Johns Hopkins University,1,2,3,9 HNO was also found to target cardiac 
sarcoplasmic ryanodine receptors to increase myocardial contractility by acting as a 
cardiac inotrope, which increases the force of contractions. HNO also interacts directly 
with thiols and other thiol-containing species, while NO cannot.1, 3, 5 The reaction of 
HNO with thiols leads to an initial formation of a putative N-hydroxysulfenamide via 
attack of a nucleophilic sulfur atom on the electrophilic nitrogen atom of HNO (Figure 
1.3a).7, 10, 11 The N-hydroxysulfenamide can further react with excess thiol (or a vicinal 
protein thiol) to give the corresponding disulfide and hydroxylamine (Figure 1.3b).7, 10, 11 
Competing with this reaction is a process whereby the N-hydroxysulfenamide rearranges 
to a sulfonamide (Figure 1.3c).7, 10, 11 
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RSH + HNO → RS-NHOH (a) 
RSNHOH + R′SH → RSSR′ + NH2OH (b) 
RSNHOH → RS(O)NH2    (c) 
Figure 1.3: Sequence of reactions for HNO and thiols 
 With all of the intriguing and unique characteristics of HNO and the potential 
therapeutic uses of the molecule, it does possess some unfortunate disadvantages. 
1.1.2 Drawbacks and issues of HNO 
HNO is not very stable in aqueous solution.4 HNO is a metastable species that 
rapidly forms dimers with other molecules of HNO (k ~ 8 x 106 M-1 s-1 (22 °C)). The 
resulting hyponitrous acid then decomposes to nitrous oxide (N2O) and water (see Figure 
1.4).7, 11 
HNO + HNO → [HO-N=N-OH] → N2O + H2O 
Figure 1.4: Equation showing the formation of the HNO dimer and subsequent 
products 
 Aside from not being very stable, HNO is quite difficult to detect and measure. 
Detection of HNO and discrimination from NO currently is done through indirect 
methods. For example, the amount of HNO can be calculated by measuring existing 
amounts of N2O after a reaction has been completed through gas chromatography (GC) 
head-space analysis, by reductive nitrosylation of oxidized metal complexes such as 
6 
 
 
 
metmyoglobin, or by the detection of reaction products of HNO reacting with thiols.4,6,12 
GC head-space analysis is less specific and convenient in bioassays because N2O can be 
formed without the intermediacy of HNO. Thus, the collection of N2O can be a 
misleading measure of HNO generation.3 Furthermore, HNO consumption in vivo is 
likely to occur largely by pathways other than dimerization (e.g., by reaction with 
glutathione (GSH) and metal- or critical-thiol proteins).3 The high reactivity of HNO with 
thiols also provides an additional indication of HNO formation due to the susceptibility to 
signal quenching by thiols such as GSH in assays.3 Miranda and coworkers utilized both 
GSH and urate as scavengers of HNO.3, 13 Many of these assays utilize biomolecules or 
have been adapted for in vitro use; these techniques cannot yet be applied to intact cells 
and they also need to be able to detect HNO and discriminate its actions from NO.4 As 
previously mentioned, at concentrations above low nanomolar values, HNO will 
kinetically undergo dimerization over deprotonation to NO−.4 Thus, studies examining 
HNO are commonly performed using HNO donors (vide infra).4 
1.1.3 Importance of HNO donors 
     Due to HNO’s inherent instability in aqueous solution, ‘HNO donors’ are 
required for biological and chemical studies of HNO reactivity and as potential 
therapeutics.9 HNO donors have been used as sources of HNO, which can induce 
biochemical reactions in biological systems. In order to fully exploit HNO as a 
pharmacological agent, a variety of donors need to be developed as replacements and/or 
complements to Angeli's salt as the primary HNO donor in biological/pharmacological 
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studies.6, 14 Use of new HNO donors can help to confirm that the observed biological 
activity is in fact due to HNO, rather than to the HNO donor itself or other reactive 
nitrogen species.6 There are a wide variety of HNO donors that have been synthesized 
and studied experimentally. 
 
 
1.2 Examples of HNO donors 
 
1.2.1 Angeli’s Salt (AS) 
Angeli’s salt (AS, Na2N2O3, Figure 1.5), has been used in clinical trials for 
treatment of acute heart failure.3,4 Angeli’s salt has been studied most extensively in 
terms of structure, thermodynamics and decomposition mechanism. 
 
Figure 1.5: The Lewis structure of Angeli’s salt 
Angeli’s salt has been the mainstay of the HNO donor field by being the most 
convenient, well-studied and utilized HNO donor.2, 3, 5, 6, 15 Angeli’s salt is a pH 
dependent donor (Figure 1.6)6 which spontaneously decomposes above pH 4 to generate 
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one equivalent each of HNO and NO2
- (k ~ 6.8 × 10−4 s−1 at 25 °C and 4.5 × 10−3 s−1 at 
37 °C).4, 6  
 
Figure 1.6: Decomposition of Angeli’s salt to form HNO 
The rate of the thermal decay of Angeli's salt is pH-independent from pH 4–8 and 
then successively decreases with elevated pH.6 These properties are extremely useful for 
practical purposes since stock solutions of Angeli's salt are relatively stable at high pH 
while the HNO release profile is pH insensitive near physiological conditions (i.e. pH 
7.4).6 At pH values less than 4, Angeli's salt converts to an NO donor.6, 16 However, its 
short half-life and concomitant release of nitrite confer limitations.6  
1.2.2 Piloty’s Acid (PA) 
N-hydroxysulfonamides (e.g. Piloty's acid, PA) are another class of HNO donor 
that has been investigated for generation of HNO.6 Figure 1.7 displays how Piloty’s acid, 
when deprotonated, can produce HNO and benzenesulfinate. 
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Figure 1.7: Reaction showing generation of HNO from Piloty’s acid 
In contrast to Angeli's salt, Piloty's acid, and its related chemical species, are 
stable at low pH and decompose with rates that are accelerated as the pH is elevated.6, 17 
The rate constant for decomposition of Piloty’s acid at pH 13 (4.2 × 10−4 s−1 at 25 °C and 
1.8 × 10−3 s−1 at 35 °C) is similar to that for Angeli’s salt at pH 4–8.4 Piloty’s acid 
decomposes at a pH above 8, which makes significant HNO release typically occur only 
at pH values well beyond biological conditions.18 At physiological pH (7.4), PA is 
oxidized and subsequently releases NO rather than HNO and the decomposition of PA is 
very slow.18 One attractive feature of Piloty’s acid is its capacity for broad substituent 
modification, enabling structural optimization of physicochemical and pharmacological 
properties.  
Piloty’s acid can be altered to make derivatives that can generate HNO more 
rapidly. Miyata synthesized several PA derivatives to observe the half-life and generation 
of HNO in a Tris buffer/20% DMSO (dimethyl sulfoxide) solution at pH 7.5 (Figure 
1.8).19 
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Figure 1.8: Piloty acid derivatives for rapid HNO release (reproduced from 
Miyata)19 
The leftmost figure shows the half-life of PA in the Tris buffer/20% DMSO 
solution at 270.2 minutes. However, with the addition of an ortho-positioned substituent, 
such as bromine (middle) or nitro (NO2, rightmost) group, the half-life was significantly 
reduced. 
Toscano also investigated PA derivatives through barbiturate analogs (Figure 
1.9).20 The analogs were able to achieve HNO release with half-lives of 0.7 min and 9.5 
min respectively in a phosphate-buffered saline (PBS) solution at pH 7.4. 
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Figure 1.9: Barbiturate analogs for the rapid release of HNO (reproduced 
from Toscano)20 
Toscano studied the synthesis of Piloty’s acid derivatives and patented his 
findings into the chemistry of their various compounds.20 Figure 1.10 shows the general 
structure of Piloty’s acid analogs with the R groups designating variable atoms and 
functional groups. 
 
Figure 1.10: Toscano patent for Piloty’s acid derivatives (reproduced from 
Toscano)21 
 Toscano patented these compounds based on the potential therapeutic advantages 
of Piloty’s acid as an HNO donor. Toscano also partnered with Cardioxyl 
Pharmaceuticals to patent some promising PA analogs that have undergone clinical 
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trials.22 CXL-1020 was the first generation HNO donor and is currently in a Phase I/IIa 
dose-escalation study to study the safety and tolerability of CXL-1020.23 Cardioxyl also 
now has a second-generation HNO donor in Phase II clinical testing named CXL-1427.23 
Structure elucidation was not entirely clear however, by checking with U.S. patents 
submitted by Toscano,21, 22 the estimated structures of two of the PA analogs are shown 
in Figure 1.11. 
 
 
Figure 1.11: Toscano’s clinical trial Piloty’s acid analogs 
1.2.3 HNO-generating diazeniumdiolates 
Although primarily known as NO donors, diazeniumdiolates (NONOates) can be 
designed to generate HNO as well.24 In fact, Angeli's salt is a diazeniumdiolate analog 
with an oxygen atom replacing the amine function (see Figure 1.5).6 
[RNH–N(O)=NO]- ⇌ [RN=N(O)–NHO-] −→ HNO + RNNO− 
Figure 1.12: General reaction scheme for NONOate generation of HNO6 
NO-releasing diazeniumdiolates are made using secondary amines,25 while 
diazeniumdiolates made with primary amines can release HNO at neutral pH and have 
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been shown to possess biological activity similar to Angeli's salt (see Figure 1.12).24 The 
byproduct of primary amine diazeniumdiolate decomposition is a nitrosamine, a species 
which is of toxicological concern.26  
1.2.4 Cyanamide 
The use of cyanamide as an anti-alcoholism drug has predated recent interest in 
HNO donors as pharmacological agents for the treatment of cardiovascular conditions 
and other applications.6 Cyanamide is bioactivated via oxidation by the enzyme catalase, 
leading to the generation of an intermediate, N-hydroxycyanamide.6 This species 
spontaneously decomposes to release cyanide and HNO (Figure 1.13).27  
 
Figure 1.13: Equation demonstrating the bioactivation of cyanamide 
However, this catalase-catalyzed reaction represents a minor pathway in the 
overall disposition of cyanamide in vivo.  
Cyanamide demonstrates both the feasibility of clinical use of HNO donors and 
the ability of such species to selectively target protein thiols, such as in aldehyde 
dehydrogenase (AlDH).6, 27 Cyanamide does not inhibit AlDH directly, but must be 
bioactivated in vivo to an active inhibitory species.27  
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1.2.5 Nitrosocarbonyls 
Compounds that generate nitrosocarbonyls are another HNO donor class. The 
nitrosocarbonyl functionality is inherently unstable in aqueous solution and 
spontaneously hydrolyzes to HNO and the corresponding carboxylic acid (Figure 1.14).6 
 
Figure 1.14: Equation showing the instability of nitrosocarbonyl compounds 
 In situ generation of nitrosocarbonyls can occur via a retro-Diels-Alder reaction 
or through oxidation of hydroxamic acids.28, 29, 30 Nagasawa attempted to generate 
nitroxyl by preparing a series of N,O-bisacylated derivatives. Such prodrugs of nitroxyl 
undergo a disproportionation reaction following ester hydrolysis to give an unstable 
acylnitro intermediate that rapidly hydrolyzes to nitroxyl.31  
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Figure 1.15: Mechanism of base/esterase catalysis of N,O-bisacylated 
derivatives (reproduced from Nagasawa)31 
Nagasawa proposed that the mechanism shown above (Figure 1.15) would 
proceed through Path A, via the intermediacy of the de-esterified compound 2. 
Elimination of arenesulfinic acid from compound 2 produces benzoylnitroxyl, which 
spontaneously hydrolyzes to give nitroxyl.31 In contrast, direct hydrolysis of the sulfonate 
group (Path B) produces the corresponding benzenesulfonic acid 5 and O-acylated 
benzohydroxamic acid 6, which hydrolyzes to benzohydroxamic acid (compound 7).31 In 
summary, Nagasawa found that N-acyloxy-O-arenesulfonylated benzenecarboximidic 
acids represent a new series of nitroxyl generators that require enzymatic activation (ester 
hydrolysis) before nitroxyl can be liberated. However, for optimal bioactivation, 
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compounds much more water-soluble than the present series are required.31 To date, 
nitrosocarbonyl precursors that generate HNO in situ have not been used extensively for 
biological studies.6 
1.2.6 Hydroxylamine 
Another example of a potential HNO donor is hydroxylamine. It has been 
hypothesized that a two electron oxidation of NH2OH could serve as a pathway to 
HNO.32 The use of NH2OH as a precursor to HNO has not been exploited as a strategy 
for HNO generation in biological studies. However, there has been a report from the 
Donzelli research group where they have indirectly demonstrated that oxidation of 
NH2OH by HRP (horseradish peroxidase) leads to release of HNO, which is trappable by 
GSH (glutathione).6, 33 
1.2.7 α-Acyloxy-C-nitroso compounds 
α-Acyloxy-C-nitroso compounds are another version of HNO donors, which were 
recently investigated by the King research group (Figure 1.16).34  
 
Figure 1.16: Reaction showing the generation of HNO by α-acyloxy-C-nitroso 
hydrolysis  
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These compounds are readily synthesized from oxidation of oximes and have 
been shown to be capable of releasing HNO under physiological conditions.6 As depicted 
in Figure 1.16, the release of HNO has been postulated to occur either by spontaneous 
hydrolysis of the ester or via esterase activity. Moreover, the release rate of HNO can be 
varied by altering the appending organic “R” groups.6 This may prove to be important in 
the future development of drugs with proper pharmacokinetics and distribution profiles.6 
1.2.8 Photolabile HNO and NO donors 
Flash photolysis is widely used for rapid in situ generation of small molecules of 
biological interest,35 including NO.36 In contrast, photochemical processes for the 
generation of HNO are not very well developed.36  However, photomediated methods for 
HNO generation offer potential advantages over traditional approaches, whereby site-
specific irradiation with a thermally-stable HNO donor could achieve both high spatial 
and temporal control during HNO generation. An example of this approach was reported 
by Toscano where HNO generation was photochemically induced through generation of 
an acyl nitroso intermediate, which then underwent another transformation en route to 
producing HNO (Figure 1.17).37 
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Figure 1.17: Photodecomposition of ethyl nitrodiazoacetate in 75:25 
acetonitrile/water (reproduced from Toscano)37 
They reported that photolytic generation of acyl nitroso compounds was on the 
nanosecond (ns) timescale.37 Figure 1.17 shows nucleophilic attack from water present in 
solution; however, acyl nitroso compounds can also react with in situ amine38 or 
thiolate37 nucleophiles to generate HNO.  
The Nakagawa research group reported completion of  photochemically mediated 
retro-hetero-Diels-Alder chemistry to generate an acyl nitroso intermediate compound 
which then can undergo hydrolytic cleavage to generate HNO in aqueous solution (Figure 
1.18).36, 39, 40, 41 However, Nakagawa suggested that the chemistry occurred thermally via 
a non-radiative relaxation process since the Woodward-Hoffman rules forbid the retro-
cycloaddition.36 Other drawbacks were that the rate of HNO generation was quite slow 
(t1/2 ~mins) and only partial decomposition of the cycloreversion precursor occurred.
36, 40 
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Figure 1.18: Example of pathway for the generation of HNO from the retro-
Diels Alder reaction (reproduced from Nakagawa)36 
In contrast to the dearth of photoactivatable HNO donors, several 
photoactivatable NO donors have been developed which possess photocleavable 
protecting groups.36 After the removal of the protecting group by photoirradation, the 
small NO molecule can be released spontaneously. For example, Tsien performed 
experiments where NONOates were caged by photocleavable protecting groups in order 
to prevent them from spontaneously decomposing to produce NO in aqueous solution.36,42 
This so called ‘‘switch-on’’ type NO donor proved very effective for time-lapse imaging 
of NO effects with fluorescence or luminescence methods.36 
Unfortunately, limitations of photocontrollable NO donors do exist. One such 
limitation is the use of UVA (blue light) irradiation, which is needed to activate certain 
photoactivatable donors for biological applications. Light in this wavelength range can be 
cytotoxic and shows poor penetration into cells and tissues.36 Nakagawa36 and Ford43 
worked on employing two-photon-absorbing NO donors to overcome this limitation 
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through the use of longer-wavelength pulse laser irradiation to provide greater 
penetration into biological tissues.36 Nakagawa found that some of his donor molecules 
were quite stable in the dark, while others were stable in ambient light without 
irradiation.44  
 
1.3 Our research group’s family of current HNO donors 
 
1.3.1 Previous work on first family of photoactivatable HNO donors 
A member of the Brasch/Sampson/Seed research group has pursued the 
development of a new class of photoactivated HNO donors for rapid HNO generation. 
The design for this HNO donor utilized the photolabile (3-hydroxy-2-naphthyl)methyl 
(HNM) OH protecting group which is shown in Figure 1.19.  
 
Figure 1.19: General strategy for photodeprotection of the HNM group 
A wide variety of photoprotecting groups exist for OH groups.45, 46 Among the 
most popular is the o-nitrobenzyl ether group, which exhibits relatively slow 
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photorelease.47, 48, 49 In contrast, Popik has reported that the HNM group undergoes very 
rapid photocleavage (krelease ~ 10
5 s-1) with good quantum (Φ = 0.17-0.26) and chemical 
yields (>90%) (Figure 1.20).50 
Figure 1.20: Mechanistic depiction of the photocleavage of the HNM Group50 
The photocleavage proceeds via photodeprotonation and rapid displacement of 
the OR group to afford a benzoxete intermediate 9. Electrocyclic ring opening affords an 
o-naphthoquinone methide byproduct (10)51 which then, reacts on the millisecond (ms) 
timeframe with water52 to afford 11. There is also an alternative approach: if the former 
phenolic byproduct is not desirable, trapping the quinone methide via a hetero-Diels-
Alder cycloaddition using a simple alkyl vinyl ether can produce a chemically benign 
hemiacetal adduct (12).  
The decision to use the HNM photoprotecting group, based on Popik’s results50, 
was because they can be cleaved in the absence of added nucleophiles and are thermally 
stable. Photodeprotection under neutral pH conditions should proceed rapidly. An anionic 
intermediate (CF3SO2NHO
-) will be formed which will rapidly decompose after the 
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initial photocleavage of the HNM group to produce HNO and a substituted sulfinate 
anion (Figure 1.21). 
 
Figure 1.21: Deprotection of HNM photoprotecting group 
 1.3.2 Previous synthesis of target photolabile HNO donors 
Three different HNMONHSO2R targets were synthesized, via the common 
synthetic strategy outlined in Figure 1.22. 
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   Figure 1.22: Previous reaction scheme for producing the first generation of 
photoactivatable HNO donors 
Starting with commercially available methyl 2-hydroxy-3-naphthoate (13), 14 
was synthesized by triisopropylsilyl chloride (TIPS-Cl) protection of the phenolic –OH. 
Then, 14 underwent reduction of the ester functional group using LiAlH4, which gave the 
corresponding alcohol 15. Unfortunately, the yields for this reaction were highly 
capricious and limited product output. The alcohol was then brominated with PBr3 (16) 
and nucleophilic substitution was effected using N-hydroxyphthalimide in basic media to 
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afford 17. Hydrazine monohydrate was then used to produce amine 18 in high yields. N-
Sulfonation with RSO2Cl, DMAP, and pyridine afforded 19. Removal of the TIPS 
protecting group was completed using TBAF (Bu4NF) in anhydrous THF to complete the 
synthesis of the 1st HNO donor 22a (room temperature, 1 hr).53, 54 Shorter reaction times 
(~ 10 min) revealed that the initial removal of the TIPS protecting group was successful; 
however, there was formation of an N-O triflyl migrated adduct 20. Figure 1.23 shows 
the structures of the desired HNO donor (22a) and the shorter reaction time adduct with 
accompanying NMR chemical shifts. 
 
 
Figure 1.23: Depiction of reaction time effect on deprotection of silyl ether 19 
Interestingly, 20 converts to 22a if the reaction is allowed to react longer (~ 1 hr). 
22a can also be generated from 19 by using potassium fluoride in tetraethylene glycol 
(KF/TEG) which promotes rapid cleavage of the TIPS protecting group (rt, 30 mins, 57% 
yield) with no evidence of forming 20. Figure 1.22 also shows a minor byproduct 
pathway which is possibly from F--mediated oxidation/N-O bond cleavage forming 21. 
Two related HNO donors 22b and 22c were also synthesized. This permitted a study of 
the sulfinate leaving groups on the HNO donor abilities of these targets. N-Sulfonation of 
18 resulted in good yields for MeSO2Cl (78% yield) and PhSO2Cl (80% yield), and 
1H NMR: δ 5.28 1H NMR: δ 5.00 
19F NMR: δ -73.6 
19F NMR: δ -76.7 
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cleavage of the TIPS protecting group also resulted in good yields (KF/TEG, 86-89% 
yield). No evidence of the byproduct 21 was observed in either case. 
 
1.4 Photolysis results from HNO donors 22 
 
1.4.1 Photolysis results of first HNO donor 22a 
The photolysis sample was prepared by dissolving 1.00 mg of HNO donor 22a in 
a mixture of CD3CN and phosphate buffer (0.16 mL CD3CN/0.64 mL phosphate buffer 
(0.1 M, pH 7.00)). The sample solution was placed in a screw-cap NMR tube in the 
glovebox to ensure no oxygen was present during the transfer. The NMR tube was 
capped, and the sample solution was irradiated under a mini-photo reactor (Rayonet 
RMR-600) with 350 nm bulbs (8 lamps) for 35 min. The sample was monitored 
periodically every 5 minutes by 19F NMR spectroscopy after irradiation (Figure 1.24). 
Based on the 19F NMR spectrum above, CF3SO2NH2 and CF3SO2
- were formed. The 
integration ratio between CF3SO2NH2 and CF3SO2
- was slightly decreased during the 
photolysis process. Another intermediate (δ -75.64) was also formed during the 
photolysis process which began to fade as photolysis was continued. The presence of 
CF3SO2
- suggested that HNO generation was indeed occurring based on the photolysis 
mechanism shown (Figure 1.25).  
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22a 
 
Figure 1.24: Photolysis of HNM-ONHSO2CF3 (22a) monitoring by 19F NMR 
spectroscopy 
 
 
 
(22a) 
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1.4.2 Proposed photolysis mechanism 
Based on the general scheme for photoremovable of the HNM group in Figure 
1.18 we proposed that the photochemistry of 22a should lead to release of HNO via the 
mechanism shown in Figure 1.25 (Pathway A).  
 
Figure 1.25: Photolysis mechanism from 22a showing the wanted and unwanted 
photolytic reactions and the products formed 
28 
 
 
 
The proposed reaction was intended to proceed via photodeprotonation of the 
phenolic OH, followed by intramolecular elimination to form the quinone methide (10) 
and an anionic intermediate (27). A series of steps then occurs to finally produce the diol 
byproduct (11) and the anionic species (27) decomposes rapidly to form HNO and the 
trifluoromethanesulfinate anion (28) (Pathway A). During photolysis of HNO donor 
molecule 22a, it was found that the generation of HNO was successful based on product 
characterization by fluorine (19F) NMR of the resulting leaving group, 
trifluoromethanesulfinate (28). In addition, the expected diol byproduct 11 was 
characterized by 1H NMR spectroscopy. However, another chemical species was found 
which accounted for 32-70% of the 19F NMR spectrum, depending on the solvent that 
was used for photolysis. It was postulated that an oxidative side reaction occurred that did 
not produce HNO, but instead formed a trifluoromethanesulfonamide byproduct 25 and 
an aldehyde species 21 (Pathway B).   
This oxidative elimination pathway is the main concern that needs to be addressed 
in order to move this project forward. A solution to halt Pathway B was critical to the 
development of this new class of photolabile HNO donor. 
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1.5 Thesis project goal 
 
1.5.1 Thesis project 
The primary aim of the thesis project was to synthesize a compound that, during 
photolysis, might not follow the oxidative elimination pathway (see Pathway B, Figure 
1.25). The target molecule incorporated an additional methyl substituent at the α-methine 
position (notified as an asterisk (*) on compound 29, Figure 1.26). It was of interest to 
understand how such a structural change would impact the selectivity between the 
different competing photolysis pathways. If competition from Pathway B could be 
suppressed, it was anticipated that clean formation of HNO via Pathway A could be 
achieved.  
 
 Figure 1.26: Comparison of original and new classes of HNO donors 
 Literature investigations revealed two possible synthetic strategies that seemed 
feasible for making the desired compound 29. The first strategy, strategy A, involved the 
use of a directed ortho-lithiation approach which utilizes the chemistry of a directing 
metalation group (DMG which is designated as –PG in Figure 1.27). Such groups assist 
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with regioselective proton abstraction56 and in our case, we were hoping to explain a 
ortho-directing metalation group to selectively lithiate A at C-3 to form the intermediate 
X. Electrophilic trapping with acetaldehyde would then afford key intermediate Z. 
Strategy B involved a longer synthesis that proceeded via reduction of B and reaction of 
Y with a methyl-organometallic nucleophile to afford the same common alcohol target Z. 
More synthetic detail into the two strategies will be discussed later in the discussion 
section of the thesis. 
 
Figure 1.27: Retrosynthetic sequence for two proposed synthetic strategies for 
developing HNO donor 29.  
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1.5.2 Proposed photolysis mechanism 
 
Figure 1.28: Projected photolytic mechanism for the new target HNO donor 29 
 It was of interest to probe how the incorporation of an additional methyl 
substituent at the benzylic position in 29 would impact the selectivity of the subsequent 
photochemistry. Our group postulated that the additional substituent at the α-methine 
carbon center (see Figure 1.26, compound 29) might inhibit the oxidative elimination 
pathway (see Figure 1.25, pathway B) that was troublesome in our 1st generation studies. 
If this was achieved, the new class of HNO donor should then only generate compound 
30 to produce HNO and the innocuous diol byproduct after hydrolysis (see Figure 1.28); 
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however, the ultimate impact of the additional methyl substituent was uncertain, and it 
remained for us to synthesize HNO donor target 29 and experimentally probe its 
selectivity for photomediated HNO generation vs the oxidative side reaction. 
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CHAPTER 2. RESULTS AND EXPERIMENTAL DISCUSSION 
 
2.1 Attempted synthesis of ɑ-methyl-substituted photolabile caged CF3SO2NH-
OHNM HNO donor 29 
 
2.1.1 Synthetic strategy A towards α-methyl-substituted CF3SO2NHOHNM HNO 
donor 29. 
As described in the introduction, two synthetic strategies were formulated to 
target the desired HNO donor compound (see Figure 1.24, compound 29). The first 
synthetic strategy involved the use of commercially available 2-naphthol and proceeded 
via the use of directed ortho-metalation (DOM) to incorporate the 2nd aromatic 
substituent at C-3. Shown below in Figure 2.1, is the synthetic route for this directed-
ortho-metalation synthetic strategy.  
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Figure 2.1: The directed ortho-metalation reaction scheme for producing the α-
methyl modified HNO donor molecule 
Good DMGs (directing metalation groups) are strong complexing or chelating 
groups that have the effect of increasing the kinetic acidity of protons which are 
positioned ortho (or adjacent to) to the DMG.56 Generally, an arene bearing a DMG 
reacting with an alkyllithium, leads to an ortho-metalated intermediate in solution, which 
can further react with an electrophile (see Figure 2.2).  
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Figure 2.2: Schematic showing the role of DMGs55 in directing ortho-
lithiation 
There was literature support to suggest that lithiation could occur selectively with 
an appropriate DMG.  
 
Figure 2.3: Chowdhury’s experiment with ortho-lithiation (reproduced from 
Chowdhury)55 
 Chowdhury55 suggested that it is possible for selective lithiation at the target site 
with the use of a methoxymethyl ether (MOM) or a methoxyl substituent.55 The MOM 
group is a strong directing metalator and can enhance the ability of alkyllithium reagents 
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(or other strong bases) to abstract protons ortho to the MOM group.55 With alkyllithium 
reagents as the base, ortho-lithiated species can be formed56 and this species can then be 
reacted with an electrophile in one-pot to form a new product. The directing ortho-
metalation (DoM) process normally demands the use of a powerful alkyllithium base 
(e.g. n-BuLi, or tert-BuLi) dissolved in organic solvents in which they exhibit high 
solubility.56 For a successful deprotonation to occur, the DMG must serve as a good 
coordinating site for alkyllithium and a poor electrophilic site for attack by a strong 
nucleophile. Steric hindrance, charge deactivation, or both may be incorporated into the 
design of the metalation director.56  
For the purpose of this project, acetaldehyde was the chosen electrophile to 
produce the alcohol 35 which could serve as a flexible intermediate en route to target 29. 
The first protection reaction involved a simple SN2 reaction involving 
deprotonation of 2-naphthol (32) with sodium hydride (NaH) followed by nucleophilic 
attack on bromomethyl methyl ether. This reaction was highly reproducible and product 
33 was obtained in very high yields (96%).  
The second step involved ortho-lithiation/electrophilic trapping. Compound 33 
was dissolved in anhydrous THF under argon to which a solution of n-BuLi in hexane 
was added dropwise while being cooled at -78 ºC. Afterwards, acetaldehyde was added 
dropwise to the same reaction flask while being cooled to -78 °C. However, the reaction 
did not produce the desired product but, instead, two ortho-substituted regioisomers 35a 
and 35 were generated in a 2:1 ratio.  
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Figure 2.4: Ortho-regioisomers 35 and 35a 
The main issue with this reaction was that the ortho-lithiation reaction was not 
selective. Compound 33 possesses two possible sites for ortho-lithiation to occur as noted 
by asterisks in Figure 2.5. 
 
Figure 2.5: Two possible ortho-lithiation sites for compound 33 
 Both of the sites noted in Figure 2.5 must be lithiated during the reaction, given 
the formation of the regioisomeric mixture of 35 and 35a (see Figure 2.4). Figure 2.6 
shows an expanded view of the 1H NMR spectrum of the crude reaction product, showing 
the α-methyl signature of 35 and its regioisomer 35a. 
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Figure 2.6: Expanded view of the 1H NMR chemical shift (ppm) of the α-
methyl substituent on the regioisomers 35a (leftmost peak) and 35 (rightmost peak). 
 The chemical shifts at 1.69 and 1.59 ppm correspond to the α-methyl substituents 
and the integration values show a 2.1:1 ratio of regioisomers. The doublet peak at 1.59 
ppm is the desired regioisomer based on other indicative peaks in the aromatic region. 
Also, the spectrum of compound 43 obtained in a later study (see Figure 2.10) confirmed 
that the 1.59 ppm peaks are indicative of the desired regioisomer 35. The 
chromatographic separation of the regioisomeric compounds 35 and 35a was not 
successful because they are structurally very similar and had similar Rf values in a range 
of solvent systems.  
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Several solvent systems were investigated, including 20% Et2O/80% petroleum 
ether, 10% DCM/90% petroleum ether, and 10%/15%/20% EtOAc/90%/85%/80% 
petroleum ether. None of the solvent systems showed any separation of the isomers.   
Several trials of the reaction were attempted where parameters were altered 
including varying the reaction temperature, reaction time and the amount of alkyllithium 
reagent employed. None of these changes proved successful and this initial synthetic 
route was put on hold.  
Later literature searching revealed that the scope of the method was limited by 
regioselectivity of the initial metalation reaction in such cases where two nonequivalent 
ortho sites are available. Harvey57 and colleagues found that metalation of 2-
(methoxymethoxy)-naphthalene with tert-BuLi followed by reaction with 
dimethylformamide (DMF) furnished two possible ortho-aldehydes in a 4:3 ratio. 
However, they did acquire their desired regioisomer, 2-hydroxy-3-naphthaldehyde, 
through the Reimer-Tieman reaction of 2-naphthol.57 The Reimer–Tiemann reaction is a 
reaction used for the ortho-formylation of phenols.57  
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Figure 2.7: Reimer-Tiemann mechanism for ortho-formylation of phenols 
Chloroform is deprotonated by a strong base (normally hydroxide) to form the 
chloroform carbanion which will quickly alpha-eliminate to give dichlorocarbene. The 
hydroxide species will also deprotonate the phenol to give a negatively charged 
phenolate. The negative charge is delocalized into the aromatic ring, making it far more 
nucleophilic and increasing its ortho selectivity. Nucleophilic attack on the 
dichlorocarbene from the ortho position gives an intermediate dichloromethyl substituted 
phenol. After elimination, the desired product is formed.  
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The Reimer-Tiemann reaction can be highly exothermic which makes it prone to 
thermal runaways and byproduct formation.57  
Other literature searching revealed that metalation of 2-methoxynaphthalene 
followed by reaction with N-methylformanilide is reported to afford the 3-formyl 
derivative (67%) accompanied by only 7% of the l-formyl isomer.57 The claim for this 
difference in product ratio was attributed to the greater steric bulk of N-
methylformanilide.57 This is unusual because regioselectivity is presumably determined 
during the initial deprotonation. In any case, this observation suggests an alternative 
method to direct formylation to a sterically less crowded ring position, which could allow 
access to the desired secondary alcohol 35 after reaction with acetaldehyde. 
Unfortunately, time constraints precluded this investigation. 
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 2.2 Reevaluation of synthetic route for producing photolabile caged 
CF3SO2NHOHNM HNO donor 29 
 
2.2.1 Second synthetic strategy (B) toward the preparation of photolabile HNO 
donor 29 
 
Figure 2.8: Original synthesis of the first photolabile caged 
CF3SO2NHOHNM HNO donor 22 
As stated previously in the introduction, a member of the Brasch/Sampson/Seed 
research group successfully synthesized our first generation of photoactivatable HNO 
donors (e.g. 22) through a seven step synthesis (see Figure 2.8). The initial reaction 
involved protection of the phenolic hydroxyl group of 13 through the use of a 
triisopropylsilyl ether. This reaction proceeded with a good yield to afford compound 14. 
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However, the reduction procedure utilizing LiAlH4 did not result in good yields of 15. 
The most optimized reaction only proceeded in 21% yield and product purification 
proved difficult. The TIPS protecting group did not survive this reaction, resulting in the 
formation of depicted diol 41. A literature search revealed that reduction was 
accompanied by unwanted intramolecular hydride transfer (see Figure 2.9).58, 59 
 
Figure 2.9: Mechanism showing the intramolecular hydride transfer during 
reduction of 14  
Saravanan et al. investigated this peculiar deprotection using varying positions of 
TBDMS protected phenols. They discovered that the proximity of the ester to silicon was 
responsible for the cleavage of the vicinal TBDMS ether.59 They synthesized a series of 
substrates where the ester was oriented α, β, and γ to the TBDMS ether, and in the cases 
of α and β esters, the TBDMS ether was reported to be cleaved.59 But with γ positioned 
esters, the TBDMS ether was only partially cleaved, while remote esters exhibited no 
cleavage of the TBDMS ether.59 It is important to note, as depicted in Figure 2.9, that the 
Al-complex needs to be present before cleavage of the silyl ether can take place.58 
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 My initial work in this area involved repeating the first two steps of the chemistry 
outlined in Figure 2.8. The first reaction, involving the protection of methyl 3-hydroxy-2-
naphthanoate 13, was carried out in reproducible yields averaging to ~80%. As found by 
the previous worker in our group, the LiAlH4 reduction of 14 to 15 did not proceed 
smoothly. Varying product yields were obtained and many of them were far from 
acceptable (2-13%). The inconsistency and poor outcome of this reduction step persuaded 
us to investigate alternative reduction conditions. 
2.2.2 Reduction step modification to the synthesis of photolabile HNO donor 29 
 
Figure 2.10: Synthetic strategy B for development of desired HNO donor 29 
13 14 
15 
42 43 44 
45 
46 29 
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Our goal was to develop alternate reducing conditions that would not suffer from 
similar Al-complex hydride transfer side reactions (see Section 2.2.1). We concluded that 
the use of a milder reducing agent, such as sodium borohydride (NaBH4), would 
hopefully improve product recovery and also prevent the loss of the TIPS protecting 
group during reduction of the ester. The challenge with using NaBH4 is that it is slow to 
react with esters by itself. However, literature searching revealed a communication 
detailing research into the reductive potential of various combinations of additives to 
reducing agents like KBH4 and NaBH4.
60 They found that the combinations of 
HfCl4/KBH4 and HfCl4/NaBH4 were  more facile, efficient, and chemoselective reducing 
systems, that reduce esters in good yields under mild conditions.60 HfCl4 has been used as 
a catalyst in organic synthesis, including intramolecular allylsilylation of alkynes,61 
esterification of carboxylic acids,62 and synthesis of benzimidazole derivatives.63 Zhang60 
postulated that NaBH4 is as active as KBH4 for the reduction of carboxylic acids and their 
derivatives to the corresponding alcohols. The reactivity of a hydride reducing agent is 
influenced by the bulkiness of the reagent and the Lewis acidity of the counter-ion.64 
HfCl4/KBH4 and HfCl4/NaBH4 undergo the formation of Hf(BH4)4 first, which is the 
active species in the reduction process.60 It is possible that Hf could also act as a Lewis 
acid and complex to the ester carbonyl oxygen and increase the electrophilicity of the 
ester. One example reported by Zhang involved the reduction of naphthoate ester 47, 
which was cleanly reduced to the primary alcohol 11 in 87% yield (Figure 2.11).60 
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Figure 2.11: HfCl4/NaCH4 reduction of an ester60 
Thus, we considered it likely that this method would be possibly useful for our 
reduction of ester 14, so long as the unwanted hydride transfer reaction could be avoided. 
However, when the reduction of ester 14 was carried out exactly as described in 
the literature source, the yield of product 15 was negligible. Different variables were 
adjusted for the reduction reaction including molar ratios of reagents, reaction time, and 
temperature of the reaction. Initially, none of the changes seemed to make a difference to 
the yield of the reaction. However, an examination of the MSDS (Material Safety Data 
Sheet) of HfCl4 revealed that the reagent is highly hygroscopic and degrades to form 
HCl. Previously we had conducted the reduction reaction under an inert atmosphere but 
had not taken rigorous precautions to exclude all air during weighing of the HfCl4. This 
discovery lead to an attempt to rigorously exclude air and oxygen throughout the entire 
procedure. All materials were collected and weighed under an inert (argon) atmosphere 
using a glove box, and the solvent, distilled THF, and starting material were all added by 
syringe to the reaction flask through a septum. The reaction progress was monitored by 
TLC to confirm that the starting material had been consumed. Table 2.1 describes all of 
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the various trials under these conditions and product yields that led to the optimization of 
the reduction procedure. 
 
Varying HfCl4/NaBH4 molar ratios and accompanying yields 
Molar equivalents 
used 
(HfCl4/NaBH4) 
Reaction 
Temperature 
(°C) 
Reaction Time  
(hours) 
Isolated  
Yield of 15 (%) 
1.32/5.26 22 1.5 (30%) 
1.4/12.69 22 42 (68%)  
1.4/3.8 24 28 (78%) 
1.25/2.9 24 22 (81%) 
 
Table 2.1: HfCl4/NaBH4 reduction of ester 14: reaction parameters 
and yields 
From carrying out various trials and scale-ups ranging from 100-300 milligram to 
gram-scale reactions, the new reduction reaction has proved to be successful and 
reproducible. The molar ratios of HfCl4 and NaBH4 were not as crucial as the reaction 
time. Zhang’s reduction of naphthoate ester 47 was complete in 1.5 hr at room 
temperature, while our reaction required ~22 hr to go to completion. The reasons behind 
this difference are unclear. One possibility could be the bulky nature of the TIPS 
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protecting group which could possibly slow the progress of the reaction due to steric 
effects, or that the reduction of 47 proceeds via complex 48 with intramolecular delivery 
of hydride, which is likely to be faster than an analogous intermolecular reduction (Figure 
2.12). 
 
Figure 2.12: Intramolecular delivery of hydride to a α-carbonyl ester 
The next step in our synthesis required oxidation of 15 to aldehyde 42 (Figure 
2.10). We found that the use of Dess-Martin periodinane (DMP)65 was an effective 
approach. This reaction was reproducible and resulted in good yields averaging about 
80%.  
The next step involved reaction of aldehyde 42 with CH3MgBr to target 
secondary alcohol 43. The Grignard reaction was also a high yielding reaction. The 
original literature procedure (used as a model for the reaction of an aldehyde with 
CH3MgBr
66) stated that the addition of the organometallic reagent was performed in two 
separate equimolar quantities. When reproducing the literature procedure, the yield of the 
reaction was moderate (~70%). The reaction procedure was adjusted slightly by adding 
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the organometallic reagent in a single portion in molar excess and the yield of the product 
43 was considerably higher (90%).  
2.2.3 Mitsunobu reaction step modification to the synthesis of photolabile HNO 
donor 29 
Previous approaches toward making our first photolabile caged 
CF3SO2NHOHNM HNO donors 22a-c (see Figure 1.22) had employed a sequence 
involving conversion of primary alcohol 15 to alkyl bromide 16, followed by SN2 
displacement with an N-alkoxyphthalimide nucleophile to afford the N-
alkoxyphthalimide 17 (see Figure 2.8). In the present synthesis, we decided to exploit an 
alternate shorter route involving a Mitsunobu reaction, which we considered should 
directly allow the conversion of secondary alcohol 43 to 44. The Mitsunobu reaction 
allows the conversion of primary and secondary alcohols to esters, phenyl ethers, 
thioethers and various other compounds.67 The nucleophile employed should be acidic, 
since one of the reagents (DIAD, diisopropylazodicarboxylate) must be protonated during 
the course of the reaction to prevent side reactions.67 The Mitsunobu reaction (Figure 
2.13) is very appealing due to its reaction scope, stereospecificity, mild reaction 
conditions, and the wide array of commercially available alcohols that can be used as 
substrates. 
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Figure 2.13: Mitsunobu reaction mechanism for the formation of compound 44 
Typical substrates for the Mitsunobu reaction are primary and secondary alcohols. 
Chiral secondary alcohols undergo complete inversion of configuration if they are not 
sterically congested.67 The nucleophilic component for the Mitsunobu reaction is usually 
a relatively acidic compound containing an O-H, S-H, or an N-H group with a pKa value 
≤ 15.67 Common nucleophiles include carboxylic acids, phenols, imides, 
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purine/pyrimidine bases, thiols and fluorinated alcohols.67  Some N-nucleophiles can then 
be further modified through hydrolysis (in the case of using phthalimide; Gabriel 
synthesis) or, selectively reduced (in the case of azide formation; Staudinger reaction) to 
make the corresponding amine accessible.67 
The Mitsunobu reaction that was investigated began by dissolving triphenyl 
phosphine (PPh3), N-hydroxyphthalimide, and alcohol 43 in freshly distilled 
dichloromethane under argon. Then, the reaction flask was cooled in an ice-water bath to 
6 °C. After cooling, diisopropylazodicarboxylate (DIAD) was added dropwise to the 
reaction flask solution.  
However, yields for our Mitsunobu reaction (43 to 44) were very poor, ranging 
from 10-15%. Literature sources stated that secondary benzyl alcohols are susceptible to 
facile Mitsunobu reactions.67 However, none of the reactions were acheived in good 
yield. Trials were performed where reaction temperature was varied but none produced a 
clean reaction or high yield. Reaction temperatures were kept between 2 – 5 °C and       
21 – 25 °C with the cooler temperature range producing slightly higher yielding 
reactions. Side reaction products were also observed from the reaction but were not fully 
characterized due to time constraints. 
A subsequent literature search revealed an interesting article published by Durand 
and coworkers.68 Durand describes the use of different bases to enhance the yield and 
purity of the Mitsunobu product along with the use of a polymer-based N-
hydroxyphthalimide reagent. The reasoning for why they decided to investigate specific 
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base effects was due to complications from rearrangement reactions during the 
Mitsunobu reaction and also during subsequent hydrazinolysis of the phthalimide moiety. 
Durand continually encountered issues with regeneration of starting alcohol and they 
attributed it to possible Lossen Rearrangement (Figure 2.14).  
 
Figure 2.14: Lossen Rearrangement mechanism proposed by Durand 
(reproduced from Durand)68 
Other investigations showed that products having an activated hydroxy group 
undergo Lossen rearrangement to isocyanates as intermediates, followed by degradation 
to primary amines in the presence of water.69 Different reaction conditions were 
examined, varying the solvent, temperature, the order of reagent addition and reaction 
time. To solve this issue, Durand and colleagues introduced a spacer between the resin 
backbone and the N-hydroxyphthalimide moiety in their polymer-supported N-
hydroxyphthalimide. The spacer increased the yield of the reaction, possibly due to relief 
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of steric effects that can limit the effectiveness of the Mitsunobu reaction.68 Durand also 
found that certain bases had a profound effect on the resulting yield of the Mitsunobu 
reaction and the purity of the products.68 The most intriguing result was when they 
compared secondary and primary alcohol reactivity with the introduction of specific 
bases. Using a reagent combination of Ph3P/DIAD/imidazole (base)/alcohol, products of 
~93% purity were obtained in ~100% yield.68 This result was quite remarkable and 
Durand could not find any correlation between the pKa of the amine base and the 
activation of the reaction. Swamy67 compiled a review article which highlighted Durand’s 
work.  
If time constraints were not an issue, the Mitusunobu reaction conditions we 
employed would have been adjusted to include imidazole to observe if purity and yield 
would have been improved based on the results that Durand obtained.  
However, due to time constraints, we were unable to further optimize the 
Mitsunobu step. The product of the Mitsunobu reaction (compound 44) can then be 
subjected to subsequent hydrazinolysis of the phthalimide group to allow access to the N-
alkoxyamine intermediate 45. Thus, we continued with 44 accumulated from our 
unoptimized reactions. Compound 44 was converted to N-alkoxyamine 45 good yield via 
hydrazinolysis. However, purification of this product proved difficult. Since compound 
45 is an N-alkoxyamine, the amine functionality can interact strongly with the silica 
stationary phase during column chromatography. As a result, the product was never 
recovered from the chromatography column. Thus, due to time constraints, the product 
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45 from the second trial of the hydrazinolysis reaction was not purified and instead was 
directly reacted with trifluoromethanesulfonyl chloride to afford compound 46. The first 
time this reaction was carried out, it was not successful. This was due to the temperature 
of the reaction not being optimal. Cooling the sulfonation reaction using an ice-salt water 
bath was not sufficient to ensure a clean monosulfonation reaction. It appeared that bis-
trifluoromethanesulfonation was occurring on compound 45 if the reaction temperature is 
not kept sufficiently low. An acetone-dry ice bath (-78 ºC) proved necessary to ensure 
that only mono-sulfonation occurs at the nitrogen in 45. After changing the reaction 
temperature to -78 ºC, the reaction yielded compound 46 in moderate yield (58%). 19F 
NMR analysis of 46 showed a clean product after column chromatography with only one 
major peak. 1H NMR analysis showed a very clean spectrum of the product. The next 
reaction involving cleavage of the TIPS protecting group to afford HNO donor 29 did not 
go smoothly. The reaction conditions were very mild; compound 46 was dissolved in a 
small amount of dichloromethane and a 0.15 M solution of potassium fluoride in 
tetraethylene glycol (KF/TEG) was added and left to stir for an hour. However, when 
attempting this reaction, TLC analysis after the first hour of the reaction showed that the 
reaction was incomplete. After four more hours of stirring, the starting material appeared 
to have been consumed and the reaction was halted. 19F NMR analysis of the crude 
product showed no evidence of the starting material and showed a single CF3SO2
- 
containing compound. The crude 1H NMR spectrum was not clean so flash 
chromatography was carried out using 30% EtOAc/70% petroleum ether as eluent. 
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Unfortunately, none of the column fractions contained the desired product 29. This may 
have been due to decomposition on the chromatography column, although this seems 
unlikely. After flushing the column with a polar solvent (EtOAc), still no desired product 
was recovered. One possibility for the lack of desired product could be that the extended 
reaction time could have allowed for the fluoride ion to cleave not only the silyl ether 
functional group but also the N-trifluoromethanesulfonate group. Fluoride ions are good 
nucleophiles in anhydrous conditions. So, the fluorine peak observed in the 19F NMR 
spectrum could have been due to the formation of CF3SO2F as a byproduct (lit. 
19F NMR: 
δ -113.8 (s, 1F, SO2F), 2.71 (d, J = 17.9 Hz, 3F, CF3)70 from the reaction. 
Due to problems with the group’s glove box, we were able to make no further 
progress with this chemistry prior to the deadline for submission of the thesis. 
Furthermore, since no appreciable amount of compound 29 could be obtained, we were 
unable to study the photochemistry of our target compound 29. 
 
2.3 Potential future goals 
 
 Optimization of the silyl-cleaving reaction and the Mitsunobu reaction are 
necessary to develop a higher yield of synthetic intermediates and ultimately HNO donor 
29. Once the synthetic reactions can be optimized, the photolysis of 29 will be studied. 
The hope of the thesis was to observe if the oxidative side reaction seen during the 
photolysis of analogous HNO donor 22 would be eliminated due to the introduction of 
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the ɑ-methyl substituent. If the photolysis indeed does show promise for eliminating the 
oxidative pathway, various R substituents can be probed at * to observe if they will 
generate HNO more cleanly or not, and other RSO2
- leaving groups can also be 
investigated to see if they impact the rate and selectivity of the photolysis leading to 
HNO generation. 
 
Figure 2.15: Schematic showing future potential ɑ-substituted HNM-ONHSO2CF3 
HNO donors 
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CHAPTER 3. EXPERIMENTAL DETAILS 
 
3.1 General considerations 
 
 Unless otherwise noted, all chemicals were used as received from the supplier 
(Sigma-Aldrich, Acros Organics, TCI America, and/or Alfa Aesar). All structural 
elucidation was performed using 1H NMR (400 MHz, Bruker Avance 400 MHz 
spectrometer running Topspin version 2.1 software with TMS as internal standard) and 
19F NMR (376 MHz) spectroscopy. Reactions were monitored using TLC (aluminum-
backed silica gel plates, Sigma-Aldrich, 200 μm layer thickness, 2-25 μm particle size 
and 60 Å pore size) or previously described NMR techniques. Column chromatography 
was typically performed under positive air pressure (flash column chromatography) using 
Fisher Scientific silica gel (SiliaFlash®, 230-400 Mesh). Anhydrous tetrahydrofuran and 
diethyl ether were distilled from sodium metal/benzophenone, anhydrous 
dichloromethane was distilled from CaH2, and all other solvents/reagents not used as 
received were purified as noted. All anhydrous solvents were distilled under argon except 
for DMF, which was used directly from the chemical supplier. When glassware is said to 
be “oven-dried”, the glass was thoroughly washed, rinsed with acetone, dried in an oven 
overnight (approx. 150° C), and cooled to room temperature. Petroleum ether (bp 66 to 
68 °C), ethyl acetate, dichloromethane and diethyl ether used in column chromatography 
were distilled prior to use. 
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3.2 Experimental details and schemes 
 
 
Figure 3.1: Synthetic scheme for the preparation of CF3SO2NH-OHNM HNO donor 
29 (Strategy A) 
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2-(Methoxymethoxy)naphthalene (33) 
 
NaH (0.872 g, 36.3 mmol) was added to a 100 mL 3-neck RB flask under argon 
in a glove box. Anhydrous THF (24 mL) was added and the flask was clamped in an ice 
bath with stirring. Some bubbles were produced indicating that the solvent was not 
entirely dry. 2-Naphthol (2.59 g, 18.0 mmol) was added to a separate 100mL RB flask 
under nitrogen gas. The compound was dissolved in anhydrous THF (12 mL) and the 
resulting solution was added dropwise by syringe to the reaction flask containing the 
NaH solution. Bubbles were observed indicating that hydrogen gas was being produced. 
The internal temperature of the reaction mixture rose to 18 °C from 0 °C. The reaction 
was left to stir for 90 minutes in the ice bath at 0°C. After that time, the reaction mixture 
was allowed to warm to room temperature. The reaction mixture was stirred at room 
temperature for 30 minutes. As the solution was stirred at room temperature, the solution 
turned a pale-yellow color. Then, methoxymethyl bromide (1.5 mL, ρ = 1.531 g/mL at 
25°C, 18.4 mmol) was added dropwise to the reaction flask with stirring. The cloudy 
yellow solution changed to a cloudy white solution. The internal temperature of the 
reaction mixture changed from 8 °C to 28 °C. The reaction was left to stir overnight for 
17 hours at room temperature. Once stirring was ceased, the solution was poured into a 
500 mL separatory funnel containing diethyl ether (70 mL). The solution was then 
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washed with water (2 x 20 mL). The aqueous layer was a dark yellow color. The 
combined organic extracts were then dried with magnesium sulfate, filtered and 
concentrated in vacuo to leave crude red colored oil (3.57 g). TLC analysis confirmed the 
starting material had been consumed (10% EtOAc/90% petroleum ether). Column 
chromatography was used to purify the crude material using 10% EtOAc/90% petroleum 
ether and 45.6 g of flash silica. After fraction 22, the eluent ratio was changed to 
20%EtOAc/80% petroleum ether. Fractions 4-24 were collected and concentrated in 
vacuo (P2O5 and paraffin wax) and the remaining material was flushed with ethyl acetate. 
After being concentrated, fractions 4-24 resulted in 3.26 g of the title compound as a red-
colored oil (96% yield). 1H NMR (400 MHz, CDCl3) δ 7.778 (d, J = 2.8 Hz, 1H), 7.752 
(s, 1H), 7.747 (d, J = 12.4 Hz, 1H), 7.436 (td, J = 6.8 Hz, 1.2 Hz, 1H), 7.399 (d, J = 2.4 
Hz, 1H), 7.350 (td, J = 8 Hz, 1.2 Hz, 1H), 7.217 (dd, J = 8.8 Hz, 2.4 Hz, 1H), 5.299 (s, 
2H), 3.526 (s, 3H). 
1-(3-(Methoxymethoxy)naphthalen-2-yl)ethanol (35) 
 
2-Methoxymethoxynaphthalene (33) (1.02 g, 5.42 mmol) was added to a 100 mL 
3-neck RB flask with a magnetic stir bar. The flask was then flushed with nitrogen gas. 
The bubbler used was equipped with a cold-temperature reading thermometer and the 
apparatus was placed in a dry ice/acetone bath to cool the reaction mixture to -78°C. 2-
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Methoxymethoxynaphthalene (33) was then dissolved in anhydrous THF (10 mL). n-
BuLi (3.5 mL, 6.1 mmol, 1.73M in cyclohexane) was added to the reaction mixture 
dropwise by syringe. The internal temperature of the reaction mixture was -74°C prior to 
the addition of n-BuLi; the temperature during addition fluctuated between -65°C and      
-71°C. The reaction mixture was left to stir for 30 minutes. After that time, the dry 
ice/acetone bath was removed and the reaction mixture was allowed to warm to room 
temperature for 50 minutes while stirring. The solution began as a dull-orange color 
which transitioned to a blood-red color and then a dark-red color. The reaction mixture 
was again placed in the dry ice/acetone bath to cool to -78°C. Acetaldehyde (0.32 mL, ρ= 
0.78 g/mL, 5.7 mmol) dissolved in anhydrous THF (6 mL) was then added dropwise by 
syringe to the reaction mixture. The internal temperature of the reaction flask fluctuated 
between -73°C and -68°C. The reaction mixture was left to stir for 17 hours while 
warming to room temperature slowly. Stirring and N2 gas protection was ceased and the 
reaction was quenched with saturated aq. NH4Cl (80 mL). The mixture was extracted 
with ethyl acetate (2 x 25 mL). The combined organic extracts were dried over sodium 
sulfate and the organic solvent was removed in vacuo to afford a bright-red colored oil 
(1.43 g). A second workup was performed to remove additional precipitated impurities. 
The crude product was then dissolved in ethyl acetate (20 mL) and washed with water 
(25 mL) and brine (25 mL) in a separatory funnel. The organic layer was dried over 
sodium sulfate and the organic solvent was removed in vacuo to afford a dull-orange oil 
(1.26 g). Column chromatography was performed on the crude material using 10% 
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EtOAc/90% petroleum ether. Fractions 2-7 collected the first impurity, fractions 9-14 
collected the starting material and the first evidence of the product spot was detected at 
fraction 17. After concentrating all of the collected fractions in vacuo, 1H NMR analysis 
of the fractions containing the product revealed that two regioisomers were present. TLC 
analysis of the product was tested with different solvent systems (20% Et2O/80% 
petroleum ether, 10% DCM/90% petroleum ether, and 10%/15%/20% 
EtOAc/90%/85%/80% petroleum ether) with all of them showing a separation of a minor 
amount of starting material and a collective streak of a major compound. The isomeric 
products could not be separated and had a collective weight of 0.91 g. The 1H NMR 
spectrum showed evidence that two isomers 35 and 35a had formed due to duplicate 
methylene peaks at 5.3 ppm and 3.5 ppm. The fraction containing the regioisomers was 
left to dry overnight in a vacuum desiccator. The weight of the regioisomeric alcohol 
products was 0.908 g (72%). 1H NMR (400 MHz, CDCl3) δ 8.198 (d, J = 8.8 Hz, 1H), 
7.840 (s, 1H), 7.744 (m, 3H), 7.471 (dt, J = 8.0 Hz, 1.2 Hz, 1H), 7.376 (m, 3H), 5.790 (br 
s, 1H), 5.293 (m, 3H), 4.771 (br s, 1H), 3.533 (s, 3H), 3.509 (s, 1H), 1.687 (d, J = 6.8 Hz, 
3H), 1.586 (d, J = 6.4 Hz, 1H). [Solvent and impurity peaks were excluded]. 
 
Figure 3.2: Synthesis of (3-(methoxymethoxy)naphthalen-2-yl)methanol 50 
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Methyl 3-(methoxymethoxy)-2-naphthoate (49) 
 
NaH (0.598 g, 24.9 mmol) was added to a 100 mL 3-neck, RB-flask under argon 
gas in a glove box along with a magnetic stirring bar. Then, the reaction flask was 
protected under a flow of N2 gas. Anhydrous THF (10 mL) was charged to the flask to 
create a gray suspension. The reaction mixture was chilled to 0° C in an ice water bath. 
Methyl 3-hydroxynaphthanoate (13) (2.52 g, 12.5 mmol) was dissolved in anhydrous 
THF (10 mL) in a separate flask under N2. The methyl 3-hydroxynaphthanoate solution 
was added dropwise (22 °C) by syringe, to the stirred reaction flask. Bubbles were 
observed indicating the release of hydrogen gas. The solution was left to stir for 10 
minutes while cooling in the ice bath (15°C  18°C). The solution turned a yellow-
orange color. Anhydrous THF (5 mL) was used to extract the remaining starting material 
from the flask which held the starting material and was added to the reaction flask. This 
caused a dark brown color to be produced which slowly changed back to the original 
yellow-orange color after the cold water bath was removed and allowed to stir for an hour 
at room temperature. Methoxymethyl bromide (1.1 mL, ρ = 1.531 g/mL at 25°C, 13 
mmol) was added dropwise by syringe to the reaction mixture [21°C  26°C]. The 
mixture changed to bright yellow and then cloudy white. The reaction mixture was left to 
stir for two hours. The reaction mixture was then quenched with water (50 mL). The 
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aqueous layer was extracted with EtOAc (2 x 25 mL). The combined organic extracts 
were dried over MgSO4, filtered, and the organic solvent was removed in vacuo to afford 
a yellow crude oil (2.60 g). TLC analysis with an eluent of 10% EtOAc/90% PET ether 
showed that product and starting material were present. Flash column chromatography 
was performed with 10% EtOAc/90% petroleum ether. After the 18th fraction, the eluent 
was changed to 20% EtOAc/80% petroleum ether. The first compound collected was the 
starting material (1.21 g, 39%) as yellow crystals. The second compound was the title 
compound (1.83 g, 60%). 1H NMR (400 MHz, CDCl3) δ 8.301 (s, 1H), 7.814 (d, J = 8.0 
Hz, 1H), 7.737 (d, J = 8.4 Hz, 1H), 7.507 (td, J = 6.0 Hz, 1H), 7.498 (s, 1H), 7.389 (td, J 
= 6.0 Hz, 1H), 5.358 (s, 2H), 3.945 (s, 3H), 3.562 (s, 3H). 
(3-(Methoxymethoxy)naphthalen-2-yl)methanol (50) 
 
To a 3-neck, 250 mL, RB-flask, LiAlH4 (0.33 g, 8.7 mmol) was suspended in 
anhydrous THF (10 mL) under argon and stirred and cooled in an ice bath to 0°C. Methyl 
3-(methoxymethoxy)-2-naphthanoate (49) (0.65 g, 2.6 mmol) was added to a separate 
flask and dissolved in anhydrous THF (10 mL) under argon. The methyl 3-
(methoxymethoxy)-2-napthanoate solution was added dropwise by syringe at room 
temperature to the main reaction flask. Bubbles were observed forming from the reaction 
mixture. The reaction mixture was left to stir for an hour and 45 minutes while warming 
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up to room temperature. The stirring was halted and the reaction mixture was quenched 
with chilled water (7 mL) and extracted using dichloromethane (2 x 10 mL). The organic 
layers were difficult to observe and aq. HCl (0.5 mL, 6M, 3.0 mmol) was added to the 
separatory funnel mixture which helped to discern between the two separate solvent 
layers. These layers were separated. The combined organic extracts were washed with 
water (25 mL) and aq. HCl (1 mL, 6M, 6.0 mmol). The organic extract was dried over 
MgSO4, filtered, and concentrated in vacuo. The product obtained was a yellow-colored 
oil which was dried in a vacuum desiccator (0.39 g, 68%). 1H NMR (400 MHz, CDCl3) δ 
7.759 (d,  J = 8.0 Hz, 1H), 7.763 (s, 1H), 7.727 (d,  J = 8.0 Hz, 1H), 7.429 (td,  J = 7.7 
Hz, 1.2 Hz, 1H), 7.401 (s, 1H), 7.359 (td,  J = 7.5 Hz, 1.6 Hz, 1H), 5.351 (s, 2H), 4.851 
(s, 2H), 3.520 (s, 3H), 1.119 (br s, 1H). 
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Figure 3.3: Synthetic scheme for CF3SO2NH-OHNM HNO donor 29 (Strategy B) 
Methyl 3-(triisopropylsilyloxy)-2-naphthoate (14) 
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Methyl 3-hydroxy-2-naphthoate (13) (3.02 g, 14.9 mmol), N, N-
(dimethylamino)pyridine (DMAP) (153 mg, 1.25 mmol), imidazole (1.58 g, 23.2 mmol), 
and anhydrous DMF (20 mL) were all added to a 3-neck, 250 mL RB flask under argon 
with stirring. Once all of the starting material and base was dissolved (15 min), TIPS-Cl 
(5.0 mL, ρ= 0.901 g/mL at 25°C, 23.4 mmol) was added dropwise by syringe at room 
temperature to the stirred reaction mixture. The solution was a golden-yellow color. The 
reaction was then left to stir at room temperature for 28 h. A 0.3 mL aliquot of the 
reaction mixture was taken and quenched with saturated aqueous sodium bicarbonate. 
Then, the product was extracted using diethyl ether and washed with brine. TLC analysis 
(using an eluent ratio of 10% EtOAc/ 90% petroleum ether) of the sample showed that 
the starting material had been consumed. Stirring of the reaction mixture was halted and 
the mixture was quenched with saturated aqueous NaHCO3 (60 mL). After being 
transferred to a 250 mL separatory funnel, diethyl ether (3 x 20 mL) was then added to 
the funnel to extract the organic products. The combined organic extracts were washed 
with brine (60 mL). Afterwards, the organic layer was dried over magnesium sulfate 
(1.77 g), filtered, and the organic solvent was removed in vacuo. Silica flash column 
chromatography was performed with 104.5 g of flash silica gel and the eluent used was a 
mixture of 5% EtOAc/ 95% petroleum ether. Fractions 11-31 were collected and the 
solvent was removed in vacuo. After drying in a vacuum desiccator for two days the title 
compound was obtained as an opaque, yellow-colored oil (4.27 g, 80%). 1H NMR (400 
MHz, CDCl3) δ 8.237 (s, 1H), 7.796 (d, J = 8.0 Hz, 1H), 7.654 (d, J = 8.0 Hz, 1H), 7.467 
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(td, J = 7.6 Hz, 1.2 Hz, 1H), 7.342 (td, J = 7.6 Hz, 1.2 Hz, 1H), 7.183 (s, 1H), 3.919 (s, 
3H), 1.373 (septet, J = 7.6 Hz, 3H), 1.144 (d, J = 7.6 Hz, 18H).   
 
(3-(Triisopropylsilyloxy)naphthalen-2-yl)methanol (15) 
 
A 250 mL 3-neck RB flask was charged with HfCl4 (1.5 g, 4.7 mmol) and NaBH4 
(0.4 g, 11 mmol) under argon in a glovebox. This mixture was then suspended in 
anhydrous THF (10 mL) to create a cream-colored suspension. The mixture was stirred 
for 10 minutes in an ice water bath (3 °C). Then, the reaction mixture was stirred for 2 
hours at room temperature (24 °C). A separately prepared solution of methyl 3-
triisopropylsilyloxy-2-naphthanoate (14) (1.32 g, 3.68 mmol) in anhydrous THF (20 mL) 
was added dropwise by syringe to the stirred reaction flask at room temperature. The 
reaction was then left to stir for 22 hours. After such time, a 0.25 mL aliquot of the 
reaction mixture was tested for the presence of the desired product by first quenching 
with water and extracting with EtOAc. Then the organic layer was washed sequentially 
with small portions of saturated aqueous sodium bicarbonate and brine. TLC analysis of 
the organic layer confirmed that the starting material had been consumed. The reaction 
mixture was slowly quenched with chilled water (40 mL) in separate 5 mL portions. An 
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exothermic reaction was observed that was accompanied by the evolution of gas. The 
mixture was then extracted using EtOAc (3 x 15 mL). The combined organic extracts 
were then washed with saturated aqueous sodium bicarbonate (40 mL) and brine (40 
mL). The organic layer was dried with Na2SO4 (2.9 g), filtered, and the organic solvent 
was removed in vacuo to leave a slightly yellow opaque oil (1.21 g). The crude product 
was then left to dry in a vacuum desiccator. After drying, the product weighed 1.09 g. 
Flash column chromatography was then performed with 109.8 g of flash silica gel and an 
eluent of 7% EtOAc/ 93% petroleum ether. After fraction 24, the eluent was changed to 
10% EtOAc/ 90% petroleum ether and the first observation of the product by TLC, was 
on fraction 36. Fractions 36-60 were collected and the solvent was removed in vacuo and 
the resulting product was then placed in a vacuum desiccator to dry overnight, to afford a 
yellow-tinted oil (0.94 g, 77% yield). 1H NMR (400 MHz, CDCl3) δ 7.771 (s, 1H), 7.761 
(d, J = 8.4 Hz, 1H), 7.656 (d, J = 8.0 Hz, 1H), 7.403 (td, J = 7.2 Hz, 1.2 Hz, 1H), 7.329 
(td, J = 7.6 Hz, 1.2 Hz, 1H), 7.138 (s, 1H), 4.867 (s, 2H), 2.239 (br s, 1H), 1.409 (septet, 
J = 7.6 Hz, 3H), 1.159 (d, J = 7.6 Hz, 18H). 
  
3-(Triisopropylsilyloxy)-2-naphthaldehyde (42) 
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To a 250 mL, 3-neck, RB flask equipped with a condenser, an argon gas line and 
a magnetic stirring bar, was added Dess-Martin periodinane (DMP) (1.48 g, 3.49 mmol). 
The reaction flask was placed in an ice-water bath. To a separate flask, alcohol 15 (0.94 
g, 2.8 mmol) was dissolved in freshly distilled dichloromethane (40 mL) that was then 
chilled under argon in a separate ice-water bath. The alcohol solution was added 
dropwise by syringe to the reaction flask in two portions (20 mL) with stirring. The 
solution turned a cloudy yellow color. The reaction mixture was then left to stir for 30 
minutes in the ice-water bath and then, for an hour at room temperature (21 °C). After 
this time, the condenser and argon gas line were removed and the reaction mixture was 
quenched with saturated aqueous sodium bicarbonate solution (30 mL) and solid sodium 
thiosulfate (2.0 g). The reaction mixture was then stirred vigorously for 10 minutes. After 
this time, the layers were separated in a separatory funnel. The organic layer was washed 
with water (3 x 50 mL) and the combined aqueous washings were extracted with diethyl 
ether (3 x 35 mL). The combined organic layers were then dried with Na2SO4 (5.0 g), 
filtered, and concentrated in vacuo to afford an orange-colored oil (0.79 g). Flash column 
chromatography was performed with 104.33 g of silica and an eluent of 7% EtOAc/ 93% 
petroleum ether. Fractions 11-31 were collected and concentrated in vacuo. The 
remaining material was placed in a vacuum desiccator for 24 hours to remove any other 
residual solvent. Then, the material was placed in a freezer for three days. The resulting 
product was a bright yellow-colored solid (0.74 g, 79%). 1H NMR (400 MHz, CDCl3) δ 
10.674 (s, 1H), 8.373 (s, 1H), 7.876 (d, J = 8.0 Hz, 1H), 7.673 (d, J = 8.0 Hz, 1H), 7.509 
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(td, J = 8.4 Hz, 1.6 Hz, 1H), 7.369 (td, J = 8 Hz, 1.2 Hz, 1H), 7.191 (s, 1H), 1.422 (septet, 
J = 8 Hz, 3H), 1.167 (d, J = 7.6 Hz, 18H). 
 
1-(3-((triisopropylsilyl)oxy)naphthalen-2-yl)ethanol (43) 
 
A 2-neck 250 mL RB-flask was equipped a condenser, a magnetic stir bar, and a 
thermometer. The reaction flask was then flushed with argon using a schlenk line. 
Aldehyde 42 (1.15 g, 3.50 mmol) was dissolved in anhydrous diethyl ether (20 mL) 
under argon and the reaction flask was then placed in an ice-water bath and chilled to      
3 °C. Methylmagnesium bromide (3.0 mL, 7.5 mmol, 3.0M in diethyl ether) was then 
added dropwise by syringe to the reaction flask (the internal temperature was 3 °C - 12 
°C). The reaction mixture was left to stir for an hour and a half while the reaction flask 
was left to progressively warm to room temperature (internal temperature 12 °C  22 
°C). Then, the reaction was stopped and the argon gas line was shut off. Saturated 
aqueous ammonium chloride (30 mL) was used to quench the reaction and protonate the 
alcohol product. The organic and aqueous layers were separated in a 125-mL separatory 
funnel. The aqueous layer was then extracted with Et2O (3 x 15 mL). The combined 
organic layers were washed with brine (30 mL), dried with magnesium sulfate and 
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concentrated in vacuo. The resulting crude yellow-tinted oil was placed in a vacuum 
desiccator for 24 hours (1.22 g). The crude product was then purified by column 
chromatography using 92 g of silica gel, and an eluent of 10% EtOAc/ 90% petroleum 
ether. Fractions 15-30 were collected and concentrated in vacuo. 1H NMR analysis of the 
product showed that solvent was still present so it was left in a freezer for six days and 
then dried in a vacuum desiccator. The product formed was a yellow-tinted viscous oil 
(1.09 g, 90% yield). 1H NMR (400 MHz, CDCl3) δ 7.848 (s, 1H), 7.769 (d, J = 7.6Hz, 
1H), 7.643 (d, J = 8.0 Hz, 1H), 7.394 (dt, J = 7.6 Hz, 1.6 Hz, 1H), 7.324 (dt, J = 7.6 Hz, 
1.2 Hz, 1H), 7.118 (s, 1H), 5.323 (m, 1H), 2.485 (d, J = 3.6 Hz, 1H), 1.593 (d, J = 6.4 Hz, 
3H), 1.435 (septet, J = 8.0 Hz, 3H), 1.166 (d, J = 7.6 Hz, 18 H). 
N-(1-(3-(Triisopropylsilyloxy)naphthalen-2-yl)ethoxy)isoindoline-1,3-dione (44) 
 
To a 100 mL, 3-neck RB-flask was added PPh3 (0.39 g, 1.5 mmol) and N-
hydroxyphthalimide (0.22 g, 1.3 mmol). Then, alcohol 43 (0.47 g, 1.4 mmol) was 
dissolved in anhydrous dichloromethane (9 mL) and added dropwise at room temperature 
(22 °C) to the reaction flask under argon. Then, an additional amount of dichloromethane 
(11 mL) was added to the reaction flask which was then cooled to 3°C in an ice-water 
bath. Then, diisopropylazodicarboxylate (0.30 mL, 1.5 mmol, 1.027 g/mL at 5 °C, 99%) 
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was added dropwise by syringe to the reaction flask (the internal temperature was            
3 °C - 6 °C. Throughout the addition, the color of the solution changed from cloudy to 
yellow, to orange and then a deep red color. After fifteen minutes, the solution changed 
from red-orange to yellow. The reaction was left to stir for 22 hours. The solvent had 
almost completely evaporated leaving a bright-yellow viscous oil, so an additional 10 mL 
of anhydrous dichloromethane was added to the reaction flask. After five minutes, a 1 mL 
aliquot was then taken and worked up using brine (2 mL) and Et2O (1 mL) after the DCM 
was evaporated. The addition of the ether to the aliquot caused a white precipitate to 
appear but, the brine redissolved this solid. TLC analysis showed no evidence of 
remaining starting material. The reaction was stopped and the dichloromethane was 
evaporated in vacuo. The crude material was dissolved in anhydrous diethyl ether (20 
mL). The organic layer was washed with brine (30 mL) in a separatory funnel. The 
aqueous layer was then washed with diethyl ether (2 x 15 mL). The combined organic 
washings were dried with Na2SO4 (1.60 g), filtered, and concentrated in vacuo. The 
resulting product was then left in a freezer for three days. The crude product (1.33 g) was 
a clumpy yellow solid and was purified by flash column chromatography using 70 g of 
silica and an eluent of 50% DCM/ 50% petroleum ether. Several fractions were collected 
(51-105) and concentrated in vacuo to yield 0.36 g of product. 1H NMR analysis showed 
that there was still DIAD in the product.  
 Further TLC test plates were used and an eluent mixture of 20% Et2O/80% 
petroleum ether showed a moderate separation of the product and the impurity with Rf 
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values of 0.29 and 0.21 respectively. 94.6 g of flash silica was then wet-packed into a 
column and the product from the 1st column was repurified by flash chromatography. The 
desired product (fractions 109-130) was concentrated in vacuo in a vacuum desiccator for 
two days. The resulting product was an off-white solid (0.10 g, 15% yield) and 1H NMR 
analysis showed that the product was pure. 1H NMR (400 MHz, CDCl3) δ 8.334 (s, 1H), 
7.890 (d, J = 8.0 Hz, 1H), 7.730 (dd, J = 8.8 Hz, 2.8 Hz, 2H), 7.664 (dd, J = 8.8 Hz, 2.8 
Hz, 2H), 7.605 (d, J = 8.4 Hz, 1H) 7.393 (dt, J = 8.0 Hz, 1.2 Hz, 1H), 7.337 (dt, J = 8.4 
Hz, 1.2 Hz, 1H) 7.053 (s, 1H), 6.169 (m, 1H), 1.720 (d, J = 6.4 Hz, 3H), 1.364 (septet, J 
= 7.6 Hz, 3H), 1.099 (d, J = 5.6 Hz, 9H), 1.081 (d, J = 5.6 Hz, 9H).     
 
O-(1-(3-(Triisopropylsilyloxy)naphthalen-2-yl)ethyl)hydroxylamine (45) 
 
To a 100 mL-3-neck RB-flask was added the phthalimide starting material 44 
(0.25 g, 0.49 mmol) dissolved in HPLC grade dichloromethane (15 mL). The reaction 
flask was equipped with a thermometer, magnetic stir bar, and a condenser. The reaction 
flask was then placed in an ice bath and chilled to 6 °C. Then, 98% hydrazine 
monohydrate (64 % hydrazine) (0.2 mL, 4.1 mmol, ρ = 1.032 g/mL at 25 °C) was added 
dropwise (6 -12 °C) to the solution. A white precipitate appeared 15 min after the initial 
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addition of hydrazine monohydrate. The reaction was then left to stir for 30 min on ice 
(10-12 °C). The ice bath was then removed and the reaction was allowed to warm to 
room temperature. TLC analysis after one hour and two hours (20%/80% Et2O/petroleum 
ether and 50%/50% DCM/petroleum ether respectively) showed no remaining starting 
material. The reaction was stopped after two hours and 25 min. The precipitate was then 
filtered off and the organic solvent was removed in vacuo to afford a crude yellow-tinted 
oil (0.245 g). This was dissolved in Et2O (1 mL) and the solvent was evaporated in 
vacuo. Argon gas was flowed into the septum capped flask to remove any atmospheric air 
and the flask was placed in a freezer for storage. After three days in the freezer, the flask 
containing the compound was placed in a vacuum desiccator for two days to evaporate 
any remaining solvent. The flask was then capped with a septum and flushed with argon 
by using a needle gas inlet and needle vent outlet. The flask was then placed back in the 
freezer for an extended period of time. A yellow-orange colored residue was obtained and 
a 1H NMR spectrum was obtained for the compound (0.196 g, crude). [Purity based on 
1H NMR, 98%] 1H NMR (400 MHz, CDCl3) δ 7.826 (s, 1H), 7.775 (d, J = 8.0 Hz, 1H), 
7.647 (d, J = 8.0 Hz, 1H), 7.384 (td, J = 7.6 Hz, 1.6 Hz, 1H), 7.315 (td, J = 7.2 Hz, 1.2 
Hz, 1H), 7.133 (s, 1H), 5.212 (q, J = 6.4 Hz, 1H), 1.910 (s, 1H), 1.746 (s, 1H), 1.474 (d, J 
= 3.6 Hz, 3H), 1.416 (m, 3H), 1.164 (d, J = 1.2 Hz, 9H), 1.146 (d, J = 1.2 Hz, 9H). 
1,1,1-Trifluoro-N-(1-(3-(triisopropylsilyloxy)naphthalen-2-
yl)ethoxy)methanesulfonamide (46) 
76 
 
 
 
 
In a 100 mL 3-neck RB-flask equipped with a magenetic stir bar, thermometer 
and condenser under an argon atmosphere, was added a mixture of alkoxyamine starting 
material 45 (0.05 g, 0.14 mmol, 3.02 mL from a 0.05 M solution of 0.10 g of 45 in 6 mL 
of dichloromethane), DMAP (0.017 g, 0.14 mmol), pyridine (0.1 mL, 1.2 mmol, 0.978 
g/mL at 25°C) in freshly distilled dichloromethane (6 mL) was prepared within the 
reaction flask. The flask was placed in an ethanol/dry ice bath and chilled to -66 °C for 15 
minutes. CF3SO2Cl (0.019 mL, 0.18 mmol, 1.583 g/mL at 25°C) was added dropwise to 
the reaction flask over a time period of 2 minutes [the internal temperature was (-66) – (-
58°C)]. The reaction was then left to warm to room temperature over a period of four 
hours [21°C]. TLC analysis was performed using 50%/50% dichloromethane/petroleum 
ether and 5%/95% Et2O/petroleum ether. Both analyses showed that no starting material 
remained. The reaction mixture was transferred to a separatory funnel and the organic 
layer was washed with aq. CuSO4* 5 H2O (25 mL) and distilled H2O (40 mL). The 
organic layer was dried using Na2SO4 (2.5 g), filtered, and concentrated in vacuo (P2O5 
and paraffin wax). An orange residue was obtained (0.05 g crude). Flash column 
chromatography was performed using 2-5% ethyl ether/ 98-95% petroleum ether and 
flash silica gel (20 g). Fractions 27-51 were collected and concentrated in vacuo over 
P2O5. The resulting product was an oily colorless residue (0.040 g, 58% yield). 
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19F NMR (CDCl3 with CFCl3, 400 MHz) δ -73.084. 1H NMR (CDCl3, 400 MHz) δ 7.783-
7.759 (m, 2H), 7.665 (d, J = 8.4 Hz, 1H), 7.475 (s, 1H), 7.429 (td, J = 8 Hz, 1.2 Hz, 1H) 
7.352 (td, J = 8 Hz, 1.2 Hz, 1H), 7.153 (s, 1H), 5.746 (m, 1H), 1.587 (d, J = 6.8 Hz, 3H), 
1.423 (m, 3H), 1.169 (d, J = 1.4 Hz, 9H), 1.151 (d, 1.3 Hz, 9H). 
 
Attempted preparation of 1,1,1-Trifluoro-N-(1-(3-hydroxynaphthalen-2-
yl)ethoxy)methanesulfonamide (29) 
 
To a 50 mL, two-neck round bottom flask containing the starting material 46 
(0.04 g, 0.08 mmol) dissolved in freshly distilled dichloromethane (0.5 mL), was added a 
magnetic stir bar and a condenser under an argon atmosphere. Then, a solution of KF in 
tetraethylene glycol (TEG) (0.0095 g, 1.0 mL, 0.16 mmol, 0.15 M in TEG) was added to 
the reaction flask while stirring. The reaction was left to stir for three and a half hours at 
which time, TLC analysis (5% Et2O/95% petroleum ether) showed no evidence of 
starting material. The reaction was then stopped and quenched with nanopure water (50 
mL) and extracted with distilled EtOAc (3 x 20 mL). The organic layer was dried using 
MgSO4 (1.9 g), filtered, and concentrated in vacuo (P2O5 and paraffin wax). The crude 
material obtained was an orange oil (0.064 g). Two purifications using flash column 
chromatography were run on the crude material. The first column (30 g of silica) was run 
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using a 10% EtOAc/90% petroleum ether eluent initially and then 30% EtOAc/70% 
petroleum ether, after fraction 66. The solvent was again changed to 50%/50% 
EtOAc/petroleum ether after fraction 115. Fractions 69-115 were collected and 
concentrated as well as further EtOAc flushing fractions; which were lost due to breaking 
the flask. [No weights could be determined due to the scale not being calibrated 
correctly.] 19F NMR analysis showed only one peak consistent with the target compound, 
however, the 1H NMR spectrum was still quite dirty. A second column was performed 
using 15% EtOAc/ 85% petroleum ether and 19 g of flash silica gel. Column fractions 
28-41 were collected and concentrated in vacuo and the product weight was 0.007 g 
(crude,  26% yield based on mass). 19F NMR (CDCl3 with CFCl3, 400 MHz) δ – 74.144. 
1H NMR (CDCl3, 400 MHz) [Proton NMR sample was contaminated. Compound 29 
could not be found in the spectrum.] 
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